Clinical trial of the efficacy and tolerability of an immunostimulant drug, composed by ribosomal fractions, in socialized paediatric patients in order to prevent recurrent respiratory infections
Clinical trial of the efficacy and tolerability of an immunostimulant drug, composed by ribosomal fractions, in socialized paediatric patients in order to prevent recurrent respiratory infections
Clinical trial of the efficacy and tolerability of an immunostimulant drug, composed by ribosomal fractions, in socialized paediatric patients in order to prevent recurrent respiratory infections
Statut
Status :
Terminé
Type d'étude
Phase IV
Age Min.
2
Ans
Age Max.
11
Ans
Genre
Tous
Aire thérapeutique :
Pneumologie
Maladie :
Infection respiratoire
Traitement :
Ribomunyl
Phase :
Phase IV
Date de début de l'étude :
25 Août 2008
End date :
14 Décembre 2009
Identifiant de l'essai :
J0022X ST 403
Identifiant EudraCT/CTIS :
2008-000487-17
Envoyer par email